Dr.Reddy’s to acquire Octoplus pharma

October 22, 2012 11:12 am | Updated 02:25 pm IST - Hyderabad

A view of Dr. Reddy's Labs facility near Hyderabad. File photo

A view of Dr. Reddy's Labs facility near Hyderabad. File photo

Dr. Reddy’s Laboratories announced the intended public offer to acquire Octoplus N.V., a service based specialty pharmaceutical company for Euro 27.39 million in cash.

Dr.Reddy’s offered to acquire 100 per cent of the issued and outstanding shares of OctoPlus with a premium of 30 per cent over the closing price of OctoPlus as on October 19.

Dr.Reddy’s already got commitment from over 50 per cent of shareholders of OctoPlus whose executive board unanimously recommended the offer to the remaining shareholders.

A release from Dr.Reddy’s said that the deal would help expand the company’s expertise and scientific capabilities. “We are looking forward to build a research base in Leiden (Netherlands). The acquisition helps us remap up our technology capabilities in drug delivery,” said Mr.G.V.Prasad, Vice-Charman and CEO of Dr.Reddy’s.

Top News Today

Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.